Polotskiĭ Iu E, Efremov V E, Bondarenko V M, Nastichkin I A, Belov A G, Kan I M, Smirnova G V, Romanova Iu M
Zh Mikrobiol Epidemiol Immunobiol. 1993 Mar-Apr(2):15-23.
In 2-3 weeks after the oral immunization of rabbits, made in one or two administrations, with attenuated two-marker S. dysenteriae 1 strain VS-12 and recombinant S. dysenteriae VS-12/S. sonnei NR-18 and S. flexneri y433/S. sonnei NR-18 pronounced immunological reaction developed in the mucous membrane of the small intestine: blast transformation follicles of Peyer's patches, an increase in the number of lymphoblasts and plasmocytes in the cupolae of follicles and in intestinal villi, and an increase in the number of lymphocytes and macrophages in the intestinal epithelium with their release into the lumen of the intestine after challenge with virulent shigellae. The protective potency of these recombinants after challenge with massive doses of virulent shigellae was found to be high, which was shown by quantitative evaluation of the decrease of adhesion, invasiveness and cytotoxicity, suppression of epithelial lesions and development of inflammation in the intestinal mucosa.
用减毒双标记痢疾志贺菌1型菌株VS-12以及重组菌痢疾志贺菌VS-12/宋内志贺菌NR-18和福氏志贺菌y433/宋内志贺菌NR-18对家兔进行一次或两次口服免疫后2 - 3周,小肠黏膜出现明显的免疫反应:派尔集合淋巴结生发中心的母细胞转化,滤泡穹窿和肠绒毛中淋巴母细胞和浆细胞数量增加,肠道上皮中淋巴细胞和巨噬细胞数量增加,在用强毒志贺菌攻击后它们释放到肠腔中。在用大剂量强毒志贺菌攻击后,这些重组菌的保护效力很高,这通过对黏附、侵袭和细胞毒性降低的定量评估、上皮损伤的抑制以及肠黏膜炎症的发展得以体现。